Roche to invest $880M on biologic manufacturing network

|About: Roche Holding Ltd ADR (RHHBY)|By:, SA News Editor

Roche (RHHBY.OB) intends to spend 800M Swiss francs ($880M) on its production facilities over the next five years and create 500 jobs.

The plan is part of Roche's strategy to prepare for increasing demand for its biologic drugs, which are proteins or cells derived from living organisms.

The investment demonstrates Roche's confidence in its pipeline and is in contrast to major peers such as Teva and Merck, which are slashing jobs and expenses. (PR)